Concepedia

Miguel‐Teodoro Hernández

MH

78

Publications

5.5K

Citations

34

H-Index

2004

Active since

Affiliations

Hospital Universitario de Canarias(Current)

Clinica Universidad de Navarra

Hospital Universitario 12 De Octubre

Instituto de Investigación Biomédica de Salamanca

Hospital Clínico Universitario Lozano Blesa

Miguel‐Teodoro Hernández is an author at Hospital Universitario de Canarias specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2004–2024

78

Publications

78

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

María‐Victoria Mateos, Miguel‐Teodoro Hernández, Pilar Giraldo et al. · New England Journal of Medicine · 2013 · 569 citations · Full text

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Laura Rosiñol, Albert Oriol, Ana Isabel Teruel et al. · Blood · 2012 · 485 citations · Full text

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials

Juan José Lahuerta, Bruno Paiva, María‐Belén Vídriales et al. · Journal of Clinical Oncology · 2017 · 305 citations · Full text

, , +13

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

Bruno Paiva, Norma C. Gutiérrez, Laura Rosiñol et al. · Blood · 2011 · 303 citations · Full text

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

Laura Rosiñol, Josè Antonio Pérez-Simón, Anna Sureda et al. · Blood · 2008 · 264 citations · Full text

Rows per page

1–5 of 78